Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes.

    Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA.

    Diabetes Care. 2008 Aug;31(8):1650-5. Epub 2008 May 16.PMID: 18487478 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.

    Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L.

    Diabetes Care. 2009 Feb;32(2):281-6. Epub 2008 Nov 18.PMID: 19017778 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

    Diabetes Care. 2006 Jul;29(7):1613-8.PMID: 16801587 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    What is the best predictor of future type 2 diabetes?

    Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M.

    Diabetes Care. 2007 Jun;30(6):1544-8. Epub 2007 Mar 23.PMID: 17384342 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge.

    Haeckel R, Raber R, Wosniok W.

    Clin Chem Lab Med. 2006;44(12):1462-71. Erratum in: Clin Chem Lab Med. 2007;45(2):276. PMID: 17163824 [PubMed - indexed for MEDLINE]Related articles

    6.

    The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.

    Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM; San Antonio Heart Study.

    Diabetes Care. 2003 Nov;26(11):3153-9.PMID: 14578254 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Prevalence of type II diabetes mellitus in population of Krakow]

    Szurkowska M, Szybiński Z, Nazim A, Szafraniec K, Jedrychowski W.

    Pol Arch Med Wewn. 2001 Sep;106(3):771-9. Polish. PMID: 11928585 [PubMed - indexed for MEDLINE]Related articles

    8.

    Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.

    Chou P, Li CL, Wu GS, Tsai ST.

    Diabetes Care. 1998 Jul;21(7):1183-7.PMID: 9653617 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.

    Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.

    Diabetes Care. 1994 May;17(5):397-404.PMID: 8062606 [PubMed - indexed for MEDLINE]Related articles

    11.

    Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

    Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.PMID: 15977101 [PubMed - indexed for MEDLINE]Related articles

    13.

    The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a chinese population with high postprandial glucose.

    Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J.

    Diabetes Care. 2004 Oct;27(10):2429-37.PMID: 15451912 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

    Stern MP, Williams K, Haffner SM.

    Ann Intern Med. 2002 Apr 16;136(8):575-81.PMID: 11955025 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.

    Amoah AG, Schuster DP, Gaillard T, Osei K.

    Ethn Dis. 2002 Fall;12(4):S3-10-7.PMID: 12477148 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.

    Rajala U, Laakso M, Qiao Q, Keinänen-Kiukaanniemi S.

    Diabetes Care. 1998 Oct;21(10):1664-9.PMID: 9773727 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.

    Motala AA, Omar MA, Gouws E.

    Diabetes Care. 1997 Jul;20(7):1101-7.PMID: 9203444 [PubMed - indexed for MEDLINE]Related articles

    19.

    Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test.

    Ishizaka N, Ishizaka Y, Yamakado M, Toda E, Koike K, Nagai R.

    Atherosclerosis. 2009 Jun;204(2):619-23. Epub 2008 Oct 30.PMID: 19056083 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas]

    Wierusz-Wysocka B, Zozulińska D, Knast B, Pisarczyk-Wiza D.

    Pol Arch Med Wewn. 2001 Sep;106(3):815-21. Polish. PMID: 11928591 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data